Nine An Medicals Ecommerce Boom Drives Record Profit Growth

Andon Health (iHealth) has achieved remarkable success in cross-border e-commerce, with a staggering 300-fold increase in profits in the first three quarters. Beyond its impressive performance, the company has also launched an employee stock ownership plan, sharing the benefits of growth with its team. Its success offers valuable insights for cross-border e-commerce sellers: choosing the right niche, building a strong brand, and sharing success with the team are crucial for achieving extraordinary results.
Nine An Medicals Ecommerce Boom Drives Record Profit Growth

Profit Surge: The "iHealth" E-Commerce Miracle

iHealth, a subsidiary of Tianjin-based Jiuan Medical and an Amazon Best Seller in healthcare categories, recently dropped a bombshell with its Q3 earnings forecast. The company projects net profits between 16-16.3 billion yuan for the first three quarters, marking an astonishing 31,800% to 32,400% year-over-year increase . The third quarter alone is expected to deliver 756 million to 1.056 billion yuan in net profit, a dramatic reversal from last year's losses.

Employee Stock Plan: Building A Shared Future

Jiuan Medical has implemented an attractive employee stock ownership program, tightly aligning staff interests with corporate growth. Eligible employees can purchase 13 million repurchased shares at 8.80 yuan per share - a significant discount from the current market price of 45-50 yuan per share. With strong financial performance continuing, participants stand to gain substantial returns.

The plan covers approximately 800 employees including executives, managers, and core technical staff. Participants can fully vest their shares upon meeting two conditions: the company achieves annual revenue exceeding 32 billion yuan, and the employee receives an "A" performance rating.

Amazon's Star Performer

iHealth's success stems from its dominant Amazon presence as a COVID test kit market leader, boasting nearly 200,000 product ratings and consistent consumer demand. The brand has also secured multiple nine-figure U.S. government contracts this year, driving both B2C and B2B growth. By mid-year, Jiuan Medical had already achieved nearly 70% of its annual revenue target.

Staggering Financial Performance

First-half financials reveal even more impressive metrics: 23.267 billion yuan in revenue (up 39,890% YoY) and 15.244 billion yuan net profit (a 277,284% increase). Most remarkably, the company maintains a 70% net profit margin , far exceeding industry standards.

Blueprint For Success

Jiuan Medical's extraordinary growth demonstrates how strategic market positioning, strong brand development, and equitable profit sharing can create exceptional business outcomes. The company's ability to capitalize on pandemic-driven demand while fostering employee loyalty through shared success offers valuable lessons for e-commerce enterprises worldwide.